Abstract:after laser irradiation, the treated sections were more similar to a non-scarring process than the control. Cosmetic outcome: visual analog scales increased in all groups (P < 0.05), but the greatest increases were observed in the 585 nm and 595 nm laser-treated groups (50% and 60%, respectively) compared with controls (30%). There were significantly higher scores with the lasers than for the control (P < 0.001) at each visit after baseline. Both the 585 nm and 595 nm PDL treatments were effective in improving… Show more
“…9,30,31 Although this study was not powered to examine differences between older and younger scars, we found that the PhGA of four of five scars younger than 6 months had greater improvement of the treated side than of the untreated control side at 3-month follow up. 9,30,31 Although this study was not powered to examine differences between older and younger scars, we found that the PhGA of four of five scars younger than 6 months had greater improvement of the treated side than of the untreated control side at 3-month follow up.…”
Section: Subanalysis Of Scars Younger Than Six Monthsmentioning
In this trial, blinded PhGA could not confirm the clinical efficacy of 1540-nm nonablative fractional laser in the treatment of hypertrophic scars, but the treatment is safe, and patients judged that the treated part had a better global appearance.
“…9,30,31 Although this study was not powered to examine differences between older and younger scars, we found that the PhGA of four of five scars younger than 6 months had greater improvement of the treated side than of the untreated control side at 3-month follow up. 9,30,31 Although this study was not powered to examine differences between older and younger scars, we found that the PhGA of four of five scars younger than 6 months had greater improvement of the treated side than of the untreated control side at 3-month follow up.…”
Section: Subanalysis Of Scars Younger Than Six Monthsmentioning
In this trial, blinded PhGA could not confirm the clinical efficacy of 1540-nm nonablative fractional laser in the treatment of hypertrophic scars, but the treatment is safe, and patients judged that the treated part had a better global appearance.
“…[22][23][24] At the final evaluation visit, there was a trend toward a significant difference between groups in VSS total score, with the nonpurpuric segments rated as better than the other conditions, although all scar segments improved over time, whether treated or not, when evaluated using global cosmetic ratings. Although this may seem surprising, it confirms the results of several other studies that used PDL with lowerenergy nonpurpuric parameters and showed significant improvements in scar appearance.…”
Nonpurpuric settings on the PDL resulted in significant improvements in the appearance of fresh surgical scars for vascularity, pliability, and VSS total scores, although all scar segments improved over time.
“…Several studies have evaluated intervention for scar remodeling starting as early as 2 weeks after the surgical procedure [4,26]. Thus, further prospective studies are warranted to decipher if there is an optimal time to improve scar remodeling.…”
Background: Non-ablative fractional resurfacing (NAFR) has been reported in case studies as an effective treatment for surgical and burn scars [Behroozan et al.,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.